291 filings
8-K
EBS
Emergent Biosolutions Inc
1 May 24
Emergent Biosolutions Reports First Quarter 2024 Financial Results
4:44pm
8-K
EBS
Emergent Biosolutions Inc
1 May 24
Emergent BioSolutions Announces Strategic Operational Changes to Stabilize Financial Position
4:05pm
8-K
EBS
Emergent Biosolutions Inc
30 Apr 24
Emergent BioSolutions Announces Amendment to its Existing Credit Facility
5:22pm
8-K
EBS
Emergent Biosolutions Inc
26 Apr 24
Departure of Directors or Certain Officers
4:30pm
8-K
EBS
Emergent Biosolutions Inc
6 Mar 24
Emergent Biosolutions Reports Fourth Quarter 2023 Financial Results
4:15pm
8-K
w73zya
21 Feb 24
Emergent BioSolutions Appoints Industry Leader Joseph C. Papa as New President and CEO
7:25am
8-K
0lo7ux0d k9ye
11 Jan 24
Other Events
7:41am
8-K
3h8ycet5ef rt
9 Jan 24
Regulation FD Disclosure
8:40am
8-K
0kofd4kuq39zx6tchi2
28 Nov 23
Other Events
7:15am
8-K
0mqxw lyany
24 Nov 23
Emergent BioSolutions Receives NYSE Notice Regarding Delayed Form 10-Q Filing
7:17am
8-K
kcwh1mrh gpqav
16 Nov 23
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
4:11pm
8-K
x53kwg
8 Nov 23
Emergent Biosolutions Reports Third Quarter 2023 Financial Results
4:21pm
8-K
ic9vyp7fu2u oo5
5 Oct 23
A Statement on Emergent’s Camden Manufacturing Facility Regulatory Status
7:42am
8-K
2ux8i
2 Oct 23
Emergent BioSolutions Names Two Pharmaceutical Industry Veterans to Board of Directors
7:49am
8-K
6d52rv02r
30 Aug 23
Other Events
6:30am
8-K
vz0cgufddqi
16 Aug 23
Emergent’s Statement Regarding the Passing of a Director of the Board
4:47pm
8-K
pbhqutya1q0prjro0
8 Aug 23
Emergent Biosolutions Reports Financial Results for Second Quarter 2023
4:12pm
8-K
nwl59zw6w dehxlpy7dp
8 Aug 23
Emergent BioSolutions Announces Strategic Steps to Strengthen Core Business and Financial Position
7:15am
8-K
m2ld5i uc
31 Jul 23
Other Events
4:26pm
8-K
qoa3necs625l8 jea9n
27 Jul 23
Departure of Directors or Certain Officers
4:48pm